iPLATO’s mobile health solutions have proven to transform patient services and reduce health inequalities across populations. Responding to international demand for mHealth the company is currently expanding into the United States, India and Europe.
Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network, participating healthcare organisations use iPLATO solutions to promote smoking cessation, weight loss, childhood immunisation, vascular checks and cancer screening as well as offer mobile services for people with diabetes, hypertension, epilepsy and HIV.
iPLATO careSUPPORT underpins our healthcare provider partners long term condition management and behavioural change programmes. It consists of a comprehensive range of modules to support patient self care.
A selection of iPLATO careSUPPORT modules:
- Medication Support - to improve patient adherence to medication.
- Carer Support - to make life easier for carers.
- Education Support - to increase motivation for treatment.
- Patient Diary - to enable self monitoring, reporting and sharing.
- Text Consultation - to allow auditable doctor-patient interaction.
Long term condition management and behavioural change is an area of rapid growth for iPLATO and mHealth. Our target conditions are:
- Smoking Cessation
- Weight Loss
- Physical Inactivity
We welcome innovative clinicians and academic institutions to get in touch to work with us to trial new concepts and develop new evidence.
London, March 8th 2013 – iPLATO Healthcare, a UK leader in mHealth, revealed today that the number of patients connected to its platform surpassed five million in late 2012. Working in partnership with healthcare commissioners, commissioning support teams and practices iPLATO added over 5,000 patients per day to the platform in 2012. The company attributes the accelerated uptake to growing patient and practitioner acceptance for mobile services as well as maturing business cases for increased provider productivity, improved public health promotion and transformed support to people with long term conditions. iPLATO expects its British network to reach 10 million patients within 2 years. The company is looking for partners to establish networks in other countries.
London, 27 September 2012 – Patients of GP practices in North Central London including Enfield, Barnet, Haringey, Camden and Islington will soon start receiving appointment reminders and health information via text message. Already in use by a large number of practices in the area this service aims to improve patient access to GP services, reduce unnecessary visits to A&E as well as informing patients about important NHS services such as cancer screening and seasonal flu immunisation.
London, 18 July 2012 – Docobo and iPLATO Healthcare announced today an alliance aimed at offering a comprehensive solution that allows clinical commissioners as well as public and community health teams to deliver systematically improved evidence based disease prevention across populations, improve patient care and avoid unnecessary admissions to secondary care.